Abstract:The incidence of thyroid cancer has increased worldwide at a rate higher than that of any other cancer. CSN6 is overexpressed in many types of cancers, and such expression is linked to oncogenic activity. However, the detailed biological functions of CSN6 in papillary thyroid cancer (PTC) have not been well characterized. We investigated CSN6 expression in PTC specimens and cell lines. We used short-hairpin RNA-mediated gene silencing to explore the biological effects of CSN6 depletion in PTC cells. The combined effects of CSN6 silencing and FH535 therapy were assessed in terms of cell viability. The mechanism by which CSN6 regulated beta-catenin expression was also analyzed. CSN6 levels were determined by real-time polymerase chain reaction (PCR) (mRNA), Western blotting, and immunochemistry (protein). The CCK-8 and migration assays and orthotopic xenograft transplantation were used to investigate the biological effects of CSN6. We assessed the combined effects of CSN6 silencing and FH535 on cell viability in vitro. We also analyzed the relationship between the CSN6 level and clinical pathological status. CSN6 was overexpressed in human PTCs, and loss of CSN6 attenuated tumor proliferation and migration both in vitro and in vivo. CSN6 stabilized beta-catenin and facilitated the epidermal-to-mesenchymal transition (EMT) in PTC cells. CSN6 positively regulated beta-catenin expression in a beta-Trcp-dependent manner and triggered expression of several EMT-related genes regulated by beta-catenin. CSN6 silencing sensitized PTC cells to FH535 therapy via downregulation of the Wnt/beta-catenin signaling pathway. Finally, in PTC patients, the level of CSN6 was significantly (inversely) correlated with tumor size, the presence of multifocal lesions, and TNM stage. CSN6 overexpression in PTC is a strong indicator of enhanced tumor aggressiveness. CSN6 promotes PTC progression by inducing the EMT. CSN6 knockdown sensitizes PTC cells to FH535 therapy via downregulation of the Wnt/beta-catenin signaling pathway.

CSN6 Positively Regulates C-Jun in a MEKK1-dependent Manner

CSN1 Inhibits C-Jun Phosphorylation and Down-Regulates Ectopic Expression of JNK1

Cooh-Terminal Src Kinase-Mediated C-Jun Phosphorylation Promotes C-Jun Degradation And Inhibits Cell Transformation

CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9

Mekk1 Mediates the Ubiquitination and Degradation of C-Jun in Response to Osmotic Stress

CDK Inhibitor P57 (kip2) is Negatively Regulated by COP9 Signalosome Subunit 6.

IKK-Mediated Regulation of the COP9 Signalosome Via Phosphorylation of CSN5

New Tumor Suppressor Cxxc Finger Protein 4 Inactivates Mitogen Activated Protein Kinase Signaling

EGF Relays Signals to COP1 and Facilitates FOXO4 Degradation to Promote Tumorigenesis

C-Jun N-Terminal Kinase Enhances Mst1-Mediated Pro-Apoptotic Signaling Through Phosphorylation At Serine 82

Data from CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer

CSN6 Mediates Nucleotide Metabolism to Promote Tumor Development and Chemoresistance in Colorectal Cancer.

Differential Regulation of C-Jun-dependent Transcription by SUMO-specific Proteases.

Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles

Differential Regulation of C-Jun Protein Plays an Instrumental Role in Chemoresistance of Cancer Cells

CUEDC2 (CUE Domain-containing 2) and SOCS3 (suppressors of Cytokine Signaling 3) Cooperate to Negatively Regulate Janus Kinase 1/signal Transducers and Activators of Transcription 3 Signaling

COP1 and GSK3β Cooperate to Promote C-Jun Degradation and Inhibit Breast Cancer Cell Tumorigenesis.

SUMOylation of Csk Negatively Modulates its Tumor Suppressor Function.

Sustained C-Jun-nh2-kinase Activity Promotes Epithelial-Mesenchymal Transition, Invasion, and Survival of Breast Cancer Cells by Regulating Extracellular Signal-Regulated Kinase Activation.

Downregulation of CSN6 Attenuates Papillary Thyroid Carcinoma Progression by Reducing Wnt/β‐catenin Signaling and Sensitizes Cancer Cells to FH535 Therapy

Extracellular Signal-Regulated Kinase 8-Mediated C-Jun Phosphorylation Increases Tumorigenesis of Human Colon Cancer